NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-103-2010-1-PCT-01 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins PCT PCT COMB PCT/US2011/037439 Expired
NIDA E-221-2010-0-PCT-02 Phenylmorpholines And Analogues Thereof PCT PCT PCT/US2011/037361 Expired
NIEHS E-298-1999-1-US-06 Inhibitors of Epoxide Hydrolase For The Treatment of Hypertension US CON 13/113,028 Abandoned
NIAMS E-073-2011-0-US-01 Blockade of TL1A-DR3 Interactions To Ameliorate T Cell Mediated Disease Pathology And Antibodies Thereof US 61/488,671 Abandoned
NCI E-262-2005-0-CA-04 Mutated Pseudomonas Exotoxins with Reduced Antigenicity CA National Stage 2616987 Issued
NCI E-188-2004-0-US-08 Nitric Oxide-Releasing Diazeniumdiolated Compounds US DIV 13/111,613 8093343 Abandoned PDF
NIAID E-125-2008-0-US-03 Monoclonal Antibodies That React With The Capsule Of Bacillus Anthracis US National Stage 13/130,044 8501182 Abandoned PDF
NCATS E-134-2010-0-JP-06 Inhibitors of human 12-Lipoxygenase JP National Stage 2013-511332 Abandoned
NCATS E-134-2010-0-PCT-02 Inhibitors of human 12-Lipoxygenase PCT PCT PCT/US11/37000 Expired
NCATS E-134-2010-0-CA-04 Inhibitors of human 12-Lipoxygenase CA National Stage 2799792 Abandoned
NCATS E-134-2010-0-AU-03 Inhibitors of human 12-Lipoxygenase AU National Stage 2011255627 Abandoned
NCI E-203-2011-1-CN-04 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers CN National Stage 201180024535.7 Abandoned
NIDA E-176-2008-0-US-03 Differentiation Of Stem Cells Into Dopaminergic Cells US National Stage 13/129,661 8628962 Abandoned PDF
NCI E-203-2011-1-PCT-01 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers PCT PCT COMB PCT/CN2011/074203 Expired
NCI E-203-2011-1-EP-03 INDENOQUINOLONE COMPOUND, PREPARATION METHOD AND USE THEREOF EP National Stage 11782937.4 Abandoned
NCI E-203-2011-0-CN-01 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers CN ORD 201010176288.X Abandoned
NIAID E-050-1997-1-US-16 Method For Detecting The Presence of a Single Target Nucleic Acid in a Sample US CON 13/108,959 8257925 Expired PDF
CC E-184-2011-0-US-01 Embolization Assistant System and Methods for Using the Same US 61/486,722 Abandoned
NIAID E-134-2011-0-US-01 Modified HIV Mosaic Envelopes Targeted To Elicit B Cell Responses US 61/486,495 Abandoned
NIMH E-175-2004-0-CA-04 Scopolamine For The Treatment Of Depression And Anxiety CA National Stage 2610025 Issued
NIA E-103-2011-0-US-01 Use of Zscan4 for Direct Reprogramming of Somatic Cells US 61/486,004 Abandoned
NIA E-084-2011-1-US-01 Compositions and Methods For Increasing The Frequency Of Homologous Recombination US 61/486,017 Abandoned
NIDDK E-129-2010-0-EP-03 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands EP National Stage 11721899.0 Issued
NCI E-167-2010-0-EP-03 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling EP National Stage 11720697.9 Issued
NCI E-167-2010-0-DE-05 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling DE EP 11720697.9 Issued
NCI E-167-2010-0-FR-07 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling FR EP 11720697.9 Issued
NCI E-167-2010-0-GB-08 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling GB EP 11720697.9 Issued
NCI E-167-2010-0-ES-06 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling ES EP 11720697.9 Issued
NCI E-167-2010-0-IT-09 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling IT EP 11720697.9 Issued
NCI E-040-2009-0-US-04 A Semiconductor For Measuring Biological Interactions US National Stage 13/128,851 8614466 Abandoned PDF
NIDDK E-129-2010-0-PCT-02 Programmable Self-Assembled Nanostructures Based On Side Chain-Modified PNA For The Multivalent Display Of Ligands PCT PCT PCT/US2011/036090 Expired
NHGRI E-090-2010-0-US-05 METHODS OF DIAGNOSING AND PROGNOSING CANCER SUCH AS MELANOMA AND METHODS OF SELECTING COMPOUNDS TO TREAT MELANOMA. US National Stage 13/055,132 Abandoned
NCATS E-134-2010-0-EP-05 Inhibitors of human 12-Lipoxygenase EP National Stage 11721629.1 Abandoned
NCI E-167-2010-0-PCT-02 Peptide-Based Inhibitor Of Interleukin 10 Or Interferon-Gamma Signaling PCT PCT PCT/US2011/036010 Expired
NCI E-081-2011-0-US-01 Tropolone Compounds For Treating Or Preventing Retroviral Infection US 61/484,779 Abandoned
NIAID E-312-2008-0-US-03 METHOD OF MAKING AN ISOLATED POPULATION OF FOXP3+ REGULATORY T CELLS US National Stage 13/060,043 8951793 Issued PDF
NCI E-150-2007-0-US-05 Compositions And Methods For Treating Pigmentary Conditions and Melanoma US National Stage 13/059,219 8946291 Abandoned PDF
NIDDK E-064-2004-0-US-25 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment US DIV 13/103,294 8318666 Expired PDF
NIAID E-242-2011-0-US-01 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing US 61/484,184 Abandoned
NIDDK E-067-2010-0-JP-08 Inverse Agonists And Neutral Antagonists For the TSH Receptor JP National Stage 2013-503984 Abandoned
NIAID E-122-2001-0-US-09 Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof US CON 13/102,936 8343499 Expired PDF
NCI E-286-2009-0-US-02 Customizable Specimen Evaluation US ORD 13/102,133 Abandoned
NCI E-117-2011-0-US-01 Recombinant Immunotoxin Targeting Mesothelin US 61/483,531 Abandoned
NINDS E-301-2007-0-CA-04 TRANSCRANIAL MAGNETIC STIMULATION SYSTEM AND METHODS CA National Stage 2610991 Issued
NCI E-024-2009-0-US-04 Gene Signature for Predicting Prognosis Of Patients With Solid Tumors US National Stage 13/127,701 8735082 Issued PDF
NIDCR E-302-2008-0-US-05 Chemoprevention Of Head And Neck Squamous Cell Carcinomas US National Stage 13/059,335 Abandoned
NICHD E-308-2008-0-US-03 Vaccine For Shigella US National Stage 13/059,051 8747863 Abandoned PDF
NIAID E-160-2010-1-PCT-01 Methods of Treating Infection: Inhhibition Of DNA Dependent Protein Kinase (DNT-PK) PCT PCT COMB PCT/US11/34774 Expired
NHLBI E-126-2011-0-US-01 Chemical modification of apolipoprotein mimetic Peptides for the production of therapeutic agents US 61/480,986 Abandoned
NCATS E-041-2010-0-PCT-02 Small Molecule Neuropeptide S Antagonists For The Treatment Of Addictive Disorders, Mood, Anxiety And Sleep Disorders PCT PCT PCT/US2011/034276 Expired